sharecast

{{ storiesRelated.title }}

Full List Of Stories
03 Jun
kier
FTSE 250 movers: Kier crumples, Centamin shines

London's FTSE 250 was down 0. 59% at 18,859. 25 in afternoon trade on Monday, with Kier leading the index lower as its share price dove by more than 30%.

03 Jun
ep software ordenador pc
KRM22's losses expand but acquisitions boost recurring revenue

KRM22 returned widened full-year losses after costs increased on Monday, though the company also reported an increase in annualised recurring revenues following a new acquisition.

03 Jun
dividendoscb5
Tricorn reinstates dividend after transportation revenues spur profit increase

Tricorn Group on Monday reported an increase in annual profits and revenue, leading the company to reinstate its final dividend.

03 Jun
china-just-tested-its-nuclear-option-trade-war
Asia report: Markets dip as China blames US for trade talk failure

Asian markets traded mostly lower on Monday, as investors maintained their gloomy outlook as the risks associated with US-China trade tensions showed no signs of abating.

03 Jun
plexus
Plexus forms JV for xmas tree and wellhead supply

Plexus Holdings on Monday formed Plexus Pressure Control Limited (PPC), a majority-owned joint venture formed with British Engines Group subsidiary BEL Valves Limited, to supply surface production xmas tree valve assemblies and wellhead annulus outlet valves.

03 Jun
british amerian tobacco, cigars, science, scientist
Microsaic jumps following mass spectrometry breakthrough

Microsaic Systems surged on Monday after reporting a technological breakthrough that it says could provide customers with "significant" cost and time savings.

03 Jun
pharmaceuticals drugs pills astrazeneca
Trials show AstraZeneca's Lynparza delaying pancreatic cancer progression

AstraZeneca announced on Monday that its Lynparza pancreatic cancer drug has returned positive phase three trial results, doubling the amount of patients with no disease progression.

03 Jun
ep cirujanosuna operacion
Smith & Nephew's acquisition of Brainlab completed

Smith & Nephew on Monday completed its acquisition of orthopaedic joint reconstruction outfit Brainlab, whose digital workflow technology is used by surgeons in more than 500 hospitals worldwide.